Short Interest in CBD Life Sciences Inc. (OTCMKTS:CBDL) Declines By 88.3%

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the recipient of a significant decrease in short interest in December. As of December 31st, there was short interest totalling 39,500 shares, a decrease of 88.3% from the December 15th total of 338,600 shares. Based on an average daily volume of 75,074,700 shares, the short-interest ratio is presently 0.0 days.

CBD Life Sciences Trading Down 20.0 %

Shares of CBDL stock traded down $0.00 during trading hours on Monday, reaching $0.00. 9,691,416 shares of the company were exchanged, compared to its average volume of 23,433,617. CBD Life Sciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.03.

About CBD Life Sciences

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.